CART Immunotherapy: Development, Success, and Translation to Malignant Gliomas and Other Solid Tumors

Overview of attention for article published in Frontiers in oncology, October 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 1 news outlet

twitter: 18 X users

Citations

dimensions_citation: 71 Dimensions

Readers on

mendeley: 218 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Ziopharm: 13 Failed Programs With 3 More On Deck

Seeking Alpha, 16 Oct 2019

Ziopharm’s history is littered with suspended and abandoned programs. We believe Ziopharm is taking an unproven TCR T therapy…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.